Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1978;57:751-755

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagemeijer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagemeijer, F.

Circulation, Vol 57, 751-755, Copyright © 1978 by American Heart Association


ARTICLES

Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction

F Hagemeijer

In 16 patients, a sustained supraventricular tachyarrhythmia occurring less than 72 hours after the first symptom of an acute myocardial infarction was treated with titrated doses of verapamil. The drug was given intravenously in 1 mg increments every minute under continuous monitoring of electrocardiogram and blood pressure. Endpoints for the administration of verapamil were the following: reversion to sinus rhythm; a ventricular rate slower than 100/min; hypotension; a pulmonary capillary wedge pressure rising above 15 mm Hg; signs of intolerance; a maximum dose of 20 mg. Reversion to sinus rhythm was observed in 7/8 patients in atrial flutter and in 1/8 patients in atrial fibrillation; in all the ventricular rate could be slowed below 100/min without untoward effects.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
A. E. Skolnick and W. H. Frishman
Calcium Channel Blockers in Myocardial Infarction
Arch Intern Med, July 1, 1989; 149(7): 1669 - 1677.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. H. Hwang, J. Danoviz, I. Pacold, N. Rad, H. S. Loeb, and R. M. Gunnar
Double-blind Crossover Randomized Trial of Intravenously Administered Verapamil: Its Use for Atrial Fibrillation and Flutter Following Open Heart Surgery
Arch Intern Med, March 1, 1984; 144(3): 491 - 494.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
C. Tommaso, T. McDonough, M. Parker, and J. V. Talano
Atrial Fibrillation and Flutter: Immediate Control and Conversion With Intravenously Administered Verapamil
Arch Intern Med, May 1, 1983; 143(5): 877 - 881.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
B. N. Singh
Pharmacological Basis for the Therapeutic Applications of Slow-Channel Blocking Drugs
Angiology, August 1, 1982; 33(8): 492 - 515.
[PDF]


Home page
ANGIOLOGYHome page
J. A. Abbott
Intravenous Antiarrhythmic Drugs: Newer Aspects of Therapy
Angiology, April 1, 1982; 33(4): 251 - 258.
[PDF]


Home page
ANN INTERN MEDHome page
H. L. WAXMAN, R. J. MYERBURG, R. APPEL, and R. J. SUNG
Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter: A Double-Blind Randomized Cross-Over Study
Ann Intern Med, January 1, 1981; 94(1): 1 - 6.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
E. M. ANTMAN, P. H. STONE, J. E. MULLER, and E. BRAUNWALD
Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects
Ann Intern Med, December 1, 1980; 93(6): 875 - 885.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. J. SUNG, B. ELSER, and R. G. McALLISTER Jr
Intravenous Verapamil for Termination of Re-Entrant Supraventricular Tachycardias: Intracardiac Studies Correlated with Plasma Verapamil Concentrations
Ann Intern Med, November 1, 1980; 93(5): 682 - 689.
[Abstract] [PDF]